LVM Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.1M | Sell |
|
|||||
|
2025
Q2 | $13.4M | Buy |
|
|||||
|
2025
Q1 | $14.5M | Sell |
|
|||||
|
2024
Q4 | $12.2M | Buy |
|
|||||
|
2024
Q3 | $14.1M | Hold |
|
|||||
|
2024
Q2 | $14.1M | Sell |
|
|||||
|
2024
Q1 | $12.7M | Buy |
|
|||||
|
2023
Q4 | $12.2M | Buy |
|
|||||
|
2023
Q3 | $10.5M | Buy |
|
|||||
|
2023
Q2 | $10.3M | Sell |
|
|||||
|
2023
Q1 | $9.62M | Sell |
|
|||||
|
2022
Q4 | $9.56M | Sell |
|
|||||
|
2022
Q3 | $9.95M | Sell |
|
|||||
|
2022
Q2 | $10.3M | Buy |
|
|||||
|
2022
Q1 | $8.64M | Buy |
|
|||||
|
2021
Q4 | $6.99M | Buy |
|
|||||
|
2021
Q3 | $5.72M | Buy |
|
|||||
|
2021
Q2 | $6.23M | Buy |
|
|||||
|
2021
Q1 | $6.27M | Buy |
|
|||||
|
2020
Q4 | $6.8M | Buy |
|